logo
Amazon Prime Day Owala Deals Mean Big Savings On Oh So Popular Bottles

Amazon Prime Day Owala Deals Mean Big Savings On Oh So Popular Bottles

Forbes10-07-2025
Owala's water bottles are an 'IYKYK' level of viral popularity, and if you are indeed in the know, you're already aware they almost never go on sale. Amazon Prime Day Owala deals have changed all that, but only for a moment. Whether you're stocking up for summer hikes, planning ahead for back-to-school or just trying to drink more water during the workday, there are some great Prime Day Owala deals worth snagging—including the internet-famous 40-ounce tumbler for just $28 and the classic FreeSip bottle for $30.
We found the best Prime Day Owala deals so you can save on various versions of the popular water ... More bottle brand. Illustration: Forbes / Image: Retailers
And you can trust us, these bottles are more than color-mixing and hype; they're reliable and highly functional. Our own supervising deals and coupons editor, Kara Cuzzone, says: 'I was skeptical about whether all the hype around Owala water bottles was truly warranted, but now I understand why they're so popular. I have one of the FreeSip designs and it's so convenient and fun to drink out of—and I love that it securely locks so I can throw it in my bag unlike the classic straw tumblers I'd been using.' Take it from Cuzzone or take it from the tens of thousands of people who rave about Owala bottles online—either way, just don't wait, because Owala Prime Day sales will be over fast.
At last check, this water bottle had more than 77,000 ratings posted on Amazon, and the vast majority were positive. Maybe it's all the color combinations. Maybe it's the brand's patented 'FreeSip' spot that lets you sip through a straw while the bottle is upright or tip it up and sip through a slot. Maybe it's the way these things seal tightly and don't leak. Or maybe it's a combination of all those factors that have made Owala water bottles so big right now.
This 24-ounce Owala bottle is a perfect size for most lifestyles. It will fit into a car's cupholder with ease and will fit securely in most bike bottle cages. As with all Owala bottles, this one is BPA-free and has a dishwasher-safe lid—it's best to clean the metal part by hand, though.
This large Owala bottle holds 40 ounces of water, but thanks to its tapered lower half, it will still fit in cupholders. You can use it with a straw or with an opening that lets you sip, and you can carry it around with ease thanks to its handle. Right now, the Owala Travel Tumbler is 30% off thanks to Prime Day deals.
Unlike many Owala bottles, this 18-ounce bottle is suitable for use with hot or cold beverages, and it will keep beverages hot or cold for hours on end thanks to its double-walled insulation. You can also pour carbonated beverages into this one. It has that patented FreeSip top that allows for using a straw or tipping it up for swigs, and comes in several varieties of that classic Owala coloring.
Your ice water will stay cold for up to 24 hours and your coffee will stay warm for up to six hours in the Owala Smooth Sip tumbler-style cup. It has a splash-resistant lid, so even though the Tumbler doesn't fully seal, you'd have to shake it pretty severely to make a mess, so go ahead and bring your morning joe on the road or top it off with water before the commute home.
At 14 ounces, it won't get too heavy even for your kindergartner to carry, yet it will offer enough hydration to get through a couple of classes in the morning or that soccer game on the weekend. And kids will adore the bright colors in the standard Owala mix-and-match pattern.
This Hulk-themed Owala water bottle is just what your superhero-obsessed kid needs. Its distinctive green and deep purple coloring combined with the unmistakable Incredible Hulk fist icon on the side seals the deal. And right now, the price is punched down by 15%.
Protect your Owala bottle and protect delicate surfaces, like that antique wooden desk of yours, at the same time thanks to this silicone sleeve designed for the base of 32-ounce Owala bottle. It quiets things down as you set your water bottle down (or drop it) and it means a scratch-free Owala bottle even when you place it on a rough surface. And with Prime Day deals driving the price down so low, this bottle 'Boot' is an accessory that's easy to snap up.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange
MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange

Yahoo

time5 minutes ago

  • Yahoo

MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange

MEI Pharma, Inc. (NASDAQ:MEIP) is one of the . On July 18, MEI Pharma, Inc. (NASDAQ:MEIP) announced securities purchase agreements for a private investment in public equity (PIPE) for the sale and purchase of 29,239,767 shares of common stock at a price of $3.42 per share. A modern pharmaceutical laboratory with research scientists working at their desks. The expected aggregate gross proceeds for the transaction come up to approximately $100 million before the exclusion of placement agent fees and other estimated offering expenses. MEI Pharma, Inc. (NASDAQ:MEIP) has plans to use all of the net proceeds for the launch of its treasury strategy focused on Litecoin. The transaction is thus a notable milestone for the company's long-term strategic plan, establishing MEI Pharma, Inc. (NASDAQ:MEIP) as the first and only publicly traded company to adopt Litecoin as a treasury reserve asset. Often referred to as 'silver to Bitcoin's gold,' Litecoin is a peer-to-peer cryptocurrency that Charlie Lee created in October 2011. The integration of Litecoin into its treasury operations has allowed MEI Pharma, Inc. (NASDAQ:MEIP) access to a decentralized monetary asset that complements its cash management framework. MEI Pharma, Inc. (NASDAQ:MEIP) is a pharmaceutical company that develops pharmaceutical compounds. Its programs include Voruciclib and ME-344. While we acknowledge the potential of MEIP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Earnings Preview: What to Expect From Ingersoll Rand's Report
Earnings Preview: What to Expect From Ingersoll Rand's Report

Yahoo

time5 minutes ago

  • Yahoo

Earnings Preview: What to Expect From Ingersoll Rand's Report

Ingersoll Rand Inc. (IR), valued at a market cap of $34.5 billion, is a globally diversified provider of mission-critical flow creation products and industrial solutions. Headquartered in Davidson, North Carolina, the company operates through two key segments: Industrial Technologies and Services, and Precision and Science Technologies. IR is expected to release its Q2 2025 earnings after the market closes on Thursday, July 31. Ahead of this event, analysts project the company to report an adjusted EPS of $0.76, a decline of 5% from $0.80 per share reported in the year-ago quarter. The company has met or surpassed Wall Street's bottom-line estimates in three of the past four quarters, while missing the estimate on one occasion. More News from Barchart Warren Buffett's Berkshire Hathaway Earns $93,150 Every Hour from Coca-Cola Dividends Alone These Are the Highest Yielding Dividend Aristocrats Today (Entire List) OpenAI CEO Sam Altman Calls DeepSeek's Bluff: 'I Don't Think They Figured Out Something Way More Efficient' Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. For fiscal 2025, analysts expect Ingersoll Rand to report an adjusted EPS of $3.22, marking an increase of 1.3% from $3.18 in fiscal 2024. In addition, its adjusted EPS is expected to grow 9.3% year-over-year to $3.52 in fiscal 2026. IR stock has crumbled 12.6% over the past 52 weeks, underperforming the S&P 500 Index's ($SPX) 13.6% gain and the Industrial Select Sector SPDR Fund's (XLI) 20.6% return during the same period. On May 1, Ingersoll Rand released its Q1 earnings, and its shares rose marginally. Its revenue rose 2.8% year-over-year to $1.7 billion, aided by recent acquisitions, but came in just below estimates. Moreover, adjusted net income declined 8.3% from the prior year to $293.2 million, also missing projections. Analysts' consensus view on IR is moderately optimistic, with a "Moderate Buy" rating overall. Among 14 analysts covering the stock, seven suggest a "Strong Buy" and seven recommend a "Hold" rating. Its mean price target of $93 represents a 8.7% premium to current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT
Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT

Yahoo

time5 minutes ago

  • Yahoo

Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT

AbbVie Inc. (NYSE:ABBV) is one of the best long term low volatility stocks to buy now. On July 10, Morgan Stanley analyst Terrence Flynn reiterated a Buy rating on AbbVie Inc. (NYSE:ABBV) and set a price target of $250.00. A pharmacist handing out a pharmaceutical drug to a patient in a drug store or chemist. AbbVie Inc. (NYSE:ABBV) reported positive fiscal Q1 2025 results that support the optimistic outlook, with adjusted diluted EPS reaching $2.46, experiencing a 6.5% growth. The company also reported $13.343 billion in net revenue for the first quarter of 2025, reflecting an 8.4% growth on a reported basis or 9.8% on an operational basis. AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology, and various other serious health conditions. While we acknowledge the potential of ABBV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store